NSC |
Compound |
Enrichment |
Correlation |
NSC 681231 |
Boronic acid, [1-[[3-(1-naphthalenyl)-2-[(4-morpholinyl carbonyl)amino]-1-oxopropyl]amino]-3-methylbutyl]-, D-(S)- |
0.0070787592519192 |
-0.37628721 |
NSC 701109 |
Null |
0.0070787592519192 |
0.54947105 |
NSC 708854 |
Null |
0.0070787592519192 |
-0.29743656 |
NSC 723741 |
Diethyl N-[4-[(3-phenyl-5,7-diaminoquinoxalin-2-yl)hydroxy]benzoyl]- L-glutamate |
0.0070787592519192 |
-0.064007763 |
NSC 658872 |
Null |
0.00838963112864928 |
-0.47474183 |
NSC 674092 |
Quinoline-4-carboxamide, N,N'-[(1,4-piperazinediyl) bis(3,1-propanediyl)]bis(2-phenyl-, dihydrochloride |
0.00838963112864928 |
-0.49753058 |
NSC 711885 |
Null |
0.00838963112864928 |
-0.33041681 |
NSC 645892 |
Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- |
0.00888636978630782 |
0.29610686 |
NSC 648365 |
Insulin-Methotrexate conjugate |
0.00888636978630782 |
-0.0065753764 |
NSC 665484 |
Null |
0.00888636978630782 |
-0.38014824 |